Gout management: Patent analytics and computational drug design explores URAT1 inhibitors landscape
Saved in:
| Main Authors: | Jiaxin Zhang, Liang Hong, Wenfei Xu, Xin Zhang, Huina Fu, Xinan Song, Jing Zhao |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Public Library of Science (PLoS)
2025-01-01
|
| Series: | PLoS ONE |
| Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12349300/?tool=EBI |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Urate-lowering drugs in the treatment of gout: The unknown about the known
by: T. S. Panevin, et al.
Published: (2021-12-01) -
Real-life results of urate-driven pharmacotherapy with three urate lowering drugs in gout: allopurinol, febuxostat and benzbromarone
by: Ioana Hotea, et al.
Published: (2023-08-01) -
Associations between lipid-lowering drugs and urate and gout outcomes: a Mendelian randomization study
by: Min Liu, et al.
Published: (2025-01-01) -
Is Urate-lowering therapy a prevention of first gout episode?
by: Michał Szczepański, et al.
Published: (2025-07-01) -
Commentaries on the updated American College of Rheumatology guidelines for the management of gout. Urate-lowering drugs (Part 1)
by: M. S. Eliseev
Published: (2020-09-01)